Hansa Biopharma up 11% after the CEO's September purchase
- Insider
- Renée Aguiar Lucander
- Role
- Chief Executive Officer
- Company
- Hansa Biopharma (HNSA)
- Transaction
- Buy
- Shares
- 47,000
- Amount
- SEK 1.5M
- Price per share
- SEK 31.98
- Trade date
- Sep 25, 2026
- Filed
- Sep 28, 2026, 3 days after the trade
- Source
- Finansinspektionen ↗
Hansa Biopharma stock traded at SEK 43.40, up 11.5% from the previous close of SEK 38.94. CEO Renée Aguiar Lucander bought shares at SEK 31.98 in September.
Renée Aguiar Lucander bought 47,000 shares on Sep 25 and filed the purchase on Sep 28, 3 days later. The first close after the purchase was SEK 33.50 on Sep 28. Against that close, the stock is up 29.6%.
It is the only disclosed buy in the last 90 days. The price was taken at 12:32 CET and is delayed by 15 to 20 minutes.
HNSA +6.1% on the day, delayed quote Nov 16
Today+11.5%At 12:32 CET, delayed
PriceSEK 43.40Previous close SEK 38.94
Disclosed buys1In the last 90 days
Since purchase+29.6%Renée Aguiar Lucander, Sep 25